Tanke Biosciences logo

Tanke Biosciences(OTC) TNBI

Market Cap$684.60KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2011)-97%
5 Year-98%
1 Year-44%
1 Month+48%
$0.03
+0.00%
+0.00Today
Tanke Biosciences last closing stock price
MetricPriceDate
Last closeUSD 0.032026-10-07
Tanke Biosciences stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+179%USD 0.012026-09-17
1 month+48.21%USD 0.022026-08-21
3 month+86%USD 0.022026-06-02
Year to date+6.08%USD 0.032025-12-31
1 year-44.2%USD 0.052025-10-07
3 year-72.1%USD 0.102023-10-03
5 year-97.64%USD 1.182021-10-08
Since inception-97.24%USD 1.012011-06-07

Tanke Biosciences Financials at a Glance

Market Cap

$684.60KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$195.21K

EPS (TTM)

-$0.01

P/E Ratio

-3.62

Dividend

$0.00

Beta (Volatility)

-0.29 (Low)

Price

$0.03

Volume

71,899

Open

$0.02

Previous Close

$0.03

Daily Range

$0.02 - $0.03

52-Week Range

$0.01 - $0.06

Estimated Earnings Date

N/A

TNBI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Tanke Biosciences

Tanke Biosciences Corporation is a company focused on developing, producing, and selling a diverse range of animal nutrition and feed additive products. With a strong presence in the People's Republic of China, Southeast Asia, and Latin America, Tanke Biosciences aims to enhance livestock health and productivity through innovative solutions.

Products and Services
  • Organic trace mineral additives marketed under the Qili brand
  • Qilicid feed acidifiers to prevent microbial spoilage
  • Herbal medicinal additives like Extra-Health and Qilimix
Growth Outlook
  • Expansion into Southeast Asia and Latin America is underway
  • Increasing demand for animal nutrition products supports growth potential
  • Focus on innovation may lead to new product development opportunities
Financial Highlights
  • Recent quarterly net income of -$47,236 indicates ongoing challenges
  • Trailing twelve months show a consistent operating loss
  • Current liabilities significantly exceed total assets, highlighting financial strain
Tanke Biosciences Corporation operates in the asset management industry, specializing in animal nutrition. The company has established a diverse product portfolio that includes organic trace mineral additives and herbal medicinal solutions. Despite facing financial challenges, including negative net income and high liabilities, Tanke Biosciences is positioned to capitalize on the growing demand for animal nutrition products. The ongoing expansion into new markets and a focus on innovation may provide avenues for future growth. Investors may find interest in the company's potential to navigate its current financial landscape while pursuing opportunities in the animal health sector.
AI Generated • Sep 19, 2026

Industry

Commercial Services and Supplies

Sector

Industrials

CEO

Vincent W. Renz, Jr., MBA

Website

www.tanke-bio.com

Headquarters

Las Vegas, NV 89128, US

TNBI Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

46.76%

Return on Capital

N/A

Return on Assets

-269.52%

Earnings Yield

-27.62%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$684.60KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

24.54M

Volume

71.90K

Avg. Volume

13.82K

Financials (TTM)

Gross Profit

-$391.00

Operating Income

-$184.62K

EBITDA

-$184.23K

Operating Cash Flow

-$25.40K

Capital Expenditure

$7.84

Free Cash Flow

-$25.39K

Cash & ST Invst.

$3.97K

Total Debt

$140.00K

Tanke Biosciences Performance Analysis

Tanke Biosciences annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 0N/A
20232023-12-31USD 0N/A
20242024-12-31USD 0N/A
20252025-12-31USD 8,430N/A
Tanke Biosciences sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-100.0%
Q42025-12-31N/A
Q12026-03-31N/A
Q22026-06-30N/A
Tanke Biosciences annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.01-86.1%
20232023-12-31USD -0.00-50.6%
20242024-12-31USD -0.005.1%
20252025-12-31USD -0.01163.4%
Tanke Biosciences sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-307.7%
Q42025-12-3120.8%
Q12026-03-3121.1%
Q22026-06-30-20.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$684.60KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$5.27K

N/A

Employees

130

N/A

Net Income

-$47.24K

+28.3%

EBITDA

-$44.59K

+28.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$3.97K

-89.4%

Total Debt

$140.00K

+0.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$140.00K

+0.0%

Return on Assets

-2.70%

N/A

Return on Invested Capital

38.11%

N/A

Free Cash Flow

-$870.00

-109.2%

Operating Cash Flow

-$869.00

-109.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LICHLivechain Inc.
$0.00-23.08%
QYBXQian Yuan Baixing, Inc.
$0.01+0.00%
CRVHChilco River Holdings, Inc.
$0.01+0.00%
IHAIInnovative Holdings Alliance, Inc.
$0.06+4.60%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$107.08-5.34%
NVDANvidia
$230.48-2.94%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$33.79+10.24%
BITOProShares Trust - ProShares Bitcoin ETF
$10.93-1.88%

Questions About TNBI

What is the current price of Tanke Biosciences?

Tanke Biosciences is trading at $0.03 per share.

What is the 52-week range for Tanke Biosciences?

Over the past 52 weeks, Tanke Biosciences has traded between $0.01 and $0.06.

How much debt does Tanke Biosciences have?

As of the most recent reporting period, Tanke Biosciences reported total debt of $140.00K.

How much cash does Tanke Biosciences have on hand?

Tanke Biosciences reported $3.97K in cash and cash equivalents in its most recent financial results.

What is Tanke Biosciences’s dividend yield?

Tanke Biosciences does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services